Journey Medical Corp (DERM)
3.43
-0.06
(-1.72%)
USD |
NASDAQ |
Apr 24, 16:00
3.43
0.00 (0.00%)
After-Hours: 17:58
Journey Medical Cash from Investing (TTM): -5.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.00M |
| September 30, 2023 | -5.00M |
| June 30, 2023 | -5.00M |
| March 31, 2023 | -5.00M |
| December 31, 2022 | -20.00M |
| Date | Value |
|---|---|
| September 30, 2022 | -21.20M |
| June 30, 2022 | -30.00M |
| March 31, 2022 | -30.00M |
| December 31, 2021 | -10.00M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-30.00M
Minimum
Mar 2022
-5.00M
Maximum
Mar 2023
-14.58M
Average
-10.00M
Median
Dec 2021
Cash from Investing (TTM) Benchmarks
| Fortress Biotech Inc | -2.103M |
| Puma Biotechnology Inc | -19.12M |
| GT Biopharma Inc | -2.009M |
| FibroGen Inc | 153.66M |
| Outlook Therapeutics Inc | -- |